Detalhe da pesquisa
1.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626517
2.
Chronic hepatitis C in the Czech Republic: Forecasting the disease burden.
Cent Eur J Public Health
; 27(2): 93-98, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31241282
3.
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 217(11): 1750-1760, 2018 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529222
4.
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
N Engl J Med
; 372(22): 2087-96, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25916341
5.
Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age.
J Infect Dis
; 223(2): 353, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215671
6.
[The importance of HPV vaccination in men]. / Význam HPV vakcinace muzu.
Cas Lek Cesk
; 155(4): 34-9, 2016.
Artigo
em Tcheco
| MEDLINE | ID: mdl-27481200
7.
[Outbreak of SARG in a neonatal intensive care unit].
Klin Mikrobiol Infekc Lek
; 22(4): 148-151, 2016 12.
Artigo
em Tcheco
| MEDLINE | ID: mdl-28147429
8.
[Biological factors influencing infectious diseases transmitted by invasive species of mosquitoes]. / Éiologické factory ovlivnující vybrané infekcní nemoci prenásené invazivními druhy komáru.
Klin Mikrobiol Infekc Lek
; 22(2): 75-85, 2016 Jun.
Artigo
em Tcheco
| MEDLINE | ID: mdl-27450526
9.
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
J Infect Dis
; 208(12): 1953-61, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904292
10.
Rotavirus vaccination in central Europe.
J Pediatr Gastroenterol Nutr
; 56(6): 586-96, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708638
11.
[Molecular biological and epidemiological -characteristics of the varicella-zoster virus (VZV)]. / Molekulárnebiologické a epidemiologické charakteristiky viru planých nestovic (VZV).
Epidemiol Mikrobiol Imunol
; 62(4): 148-52, 2013 Dec.
Artigo
em Tcheco
| MEDLINE | ID: mdl-24467176
12.
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.
Cent Eur J Public Health
; 21(4): 233-6, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24592732
13.
Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response.
J Virol Methods
; 322: 114831, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37838083
14.
Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and Israel.
Cent Eur J Public Health
; 20(2): 121-5, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22966736
15.
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Vaccine
; 39(19): 2643-2651, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858718
16.
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
Lancet
; 374(9698): 1339-50, 2009 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19837254
17.
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.
BMC Infect Dis
; 10: 168, 2010 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546586
18.
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
Lancet Infect Dis
; 19(3): 287-297, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765242
19.
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Hum Vaccin Immunother
; 15(12): 2865-2872, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216205
20.
Vaccination in newly arrived immigrants to the European Union.
Vaccine
; 36(36): 5385-5390, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28602605